Effective aminoglycoside antibiotic for multidrug-resistant bacteria
US10617704B2 · kind B2 · utility
1Cited by
10References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 29, 2016 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Jul 29, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the following general formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition thereof, and the use thereof to prevent or treat infectious diseases and a method to prevent or treat infectious diseases using those regimen are disclosed. The compound represented by formula (I) has an antibacterial activity against both gram-positive and gram-negative bacteria, and is useful in the prevention or treatment of infectious diseases caused by these bacteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.